-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Codeine + Dipyrone) in Post-Operative Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Codeine + Dipyrone) in Post-Operative Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Codeine + Dipyrone) in Post-Operative Pain Drug Details: The fixed...
-
Product Insights
Allergic Rhinitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Allergic Rhinitis - Drugs In Development, 2023’, provides an overview of the Allergic Rhinitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Endometriosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Endometriosis - Drugs In Development, 2023’, provides an overview of the Endometriosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endometriosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Leiomyoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Leiomyoma - Drugs In Development, 2023’, provides an overview of the Leiomyoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leiomyoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Uterine Leiomyoma (Uterine Fibroids) – Drugs In Development, 2023
Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Drugs In Development, 2023’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Nasopharyngitis (Common Cold) – Drugs In Development, 2023
Global Markets Direct’s, ‘Nasopharyngitis (Common Cold) - Drugs In Development, 2023’, provides an overview of the Nasopharyngitis (Common Cold) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nasopharyngitis (Common Cold), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Eurofarma – Montes Claros Pharmaceutical Production Plant – Minas Gerais
Equip yourself with the essential tools needed to make informed and profitable decisions with our Eurofarma - Montes Claros Pharmaceutical Production Plant - Minas Gerais report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Thematic Analysis
Impact of Brazil on the Pharmaceutical Industry – Thematic Intelligence
Brazil Pharmaceutical Market Report Overview Brazil is the largest pharmaceutical market in Central/Southern America and is the 12th largest in the world. Brazil is an untapped market for big pharma manufacturing, with domestic companies dominating the marketed products landscape. The domestic pharmaceutical companies will continue to grow due to favorable policies provided by the Brazilian government to promote domestic production of medicines. Furthermore, over the years, Brazil has elevated its infrastructure, scientific, and technological facilities and has created a sustainable...
-
Product Insights
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostate cancer usually occurs in older men. Its symptoms include problems while urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips, or thighs, bone pain, and erectile dysfunction. The Prostate Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (codeine + dipyrone)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (codeine + dipyrone) Drug Details The fixed dose combination of dipyrone and codeine is...